Abstract
Background: Peripheral neuropathy is the dose-limiting toxicity of stavudine and didanosine (nucleoside analogs used in HIV treatment) and is attributed to mitochondrial toxicity from these drugs. Acetyl L-carnitine (ALC) and co-enzyme Q10 are proposed as neuropathy treatments, but evidence to support these is limited. Methods: We examined ALC and a water-soluble formulation of co-enzyme Q10 (HQO™) for the prevention of d4T and ddI neurotoxicity using cultured fetal rat DRG as an in vitro model. Results: DdI (33μM) and d4T (50μM) caused clear toxicity (impaired neurite growth) by day 8 of DRG culture. HQO™ at concentrations 1-100μM completely prevented the toxicity of 33μM ddI in vitro and ALC at concentrations 1-100 μM substantially (but incompletely) prevented ddI toxicity in this model. In contrast, ALC was ineffective at all concentrations tested for preventing the toxicity of 50μM d4T. HQO™ showed dose-dependent efficacy for preventing d4T toxicity. HQO™ (1μM) partially prevented d4T toxicity while 10 and 100μM HQO™ completely prevented d4T toxicity in this model. Conclusions: We find HQO™ is superior to ALC for preventing the neurotoxicity of d4T (the HIV treatment most associated with neuropathy) and ddI in vitro. Further study is needed to clarify any clinical role for co-enzyme Q10 coadministration with d4T and ddI and to assess whether this compound may have a role in treating established cases of neuropathy.
Keywords: HIV, stavudine, neuropathy, coenzyme Q10, acetyl L-carnitine
Current HIV Research
Title: Ubisol-AquaTM: Coenzyme Q10 Prevents Antiretroviral Toxic Neuropathy in an In Vitro Model
Volume: 8 Issue: 3
Author(s): Catherine L. Cherry, Masqura Mobarok, Steven L. Wesselingh, Randi Fain, Shelley Weinstock, Gilda Tachedjian, Seema Srivastava, David P. Tyssen, Jonathan D. Glass and David J. Hooker
Affiliation:
Keywords: HIV, stavudine, neuropathy, coenzyme Q10, acetyl L-carnitine
Abstract: Background: Peripheral neuropathy is the dose-limiting toxicity of stavudine and didanosine (nucleoside analogs used in HIV treatment) and is attributed to mitochondrial toxicity from these drugs. Acetyl L-carnitine (ALC) and co-enzyme Q10 are proposed as neuropathy treatments, but evidence to support these is limited. Methods: We examined ALC and a water-soluble formulation of co-enzyme Q10 (HQO™) for the prevention of d4T and ddI neurotoxicity using cultured fetal rat DRG as an in vitro model. Results: DdI (33μM) and d4T (50μM) caused clear toxicity (impaired neurite growth) by day 8 of DRG culture. HQO™ at concentrations 1-100μM completely prevented the toxicity of 33μM ddI in vitro and ALC at concentrations 1-100 μM substantially (but incompletely) prevented ddI toxicity in this model. In contrast, ALC was ineffective at all concentrations tested for preventing the toxicity of 50μM d4T. HQO™ showed dose-dependent efficacy for preventing d4T toxicity. HQO™ (1μM) partially prevented d4T toxicity while 10 and 100μM HQO™ completely prevented d4T toxicity in this model. Conclusions: We find HQO™ is superior to ALC for preventing the neurotoxicity of d4T (the HIV treatment most associated with neuropathy) and ddI in vitro. Further study is needed to clarify any clinical role for co-enzyme Q10 coadministration with d4T and ddI and to assess whether this compound may have a role in treating established cases of neuropathy.
Export Options
About this article
Cite this article as:
Cherry Catherine L., Mobarok Masqura, Wesselingh Steven L., Fain Randi, Weinstock Shelley, Tachedjian Gilda, Srivastava Seema, Tyssen David P., Glass Jonathan D. and Hooker David J., Ubisol-AquaTM: Coenzyme Q10 Prevents Antiretroviral Toxic Neuropathy in an In Vitro Model, Current HIV Research 2010; 8 (3) . https://dx.doi.org/10.2174/157016210791111106
DOI https://dx.doi.org/10.2174/157016210791111106 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
C-peptide and Neuropathy in Type 1 Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial (Thematic Issue: Aging and Metabolic Syndrome: Common Molecular Pathways)
Current Diabetes Reviews Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives
Current Medicinal Chemistry Recent Evidence of the Regulatory Role of PPARs in Neural Stem Cells and Their Underlying Mechanisms for Neuroprotective Effects
Current Stem Cell Research & Therapy Diabetes, Diabetic Complications, and Phosphate Toxicity: A Scoping Review
Current Diabetes Reviews <i>In-Silico</i> Validation and Fabrication of Matrix Diffusion-Based Polymeric Transdermal Patches for Repurposing Gabapentin Hydrochloride in Neuropathic Pain
CNS & Neurological Disorders - Drug Targets The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions
Current Diabetes Reviews Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): A Relationship with Implications for Vascular Risk?
Current Vascular Pharmacology UKPDS Risk Engine, Decode and Diabetes PHD Models for the Estimation of Cardiovascular Risk in Patients with Diabetes
Current Diabetes Reviews Smoking and Eye Pathologies. A Systemic Review. Part II. Retina Diseases, Uveitis, Optic Neuropathies, Thyroid-Associated Orbitopathy
Current Pharmaceutical Design The Potential Role of Thiamine (Vitamin B1) in Diabetic Complications
Current Diabetes Reviews The Impact of Bariatric Surgery in Patients with Type-2 Diabetes Mellitus
Current Diabetes Reviews Curcumin Activates Erythrocyte Membrane Acetylcholinesterase
Letters in Drug Design & Discovery The Ayurvedic Bhasma: The Ancient Science of Nanomedicine
Recent Patents on Nanomedicine Chromogranin A and the Endothelial Barrier Function
Current Medicinal Chemistry Hypoglycemia and Cardiac Arrhythmia; Mechanisms, Evidence Base a nd Current Recommendations
Current Diabetes Reviews Targeting Cancer and Neuropathy with Histone Deacetylase Inhibitors:Two Birds with One Stone?
Current Cancer Drug Targets Faujasiopsis flexuosa (Lam.) C. Jeffrey (Asteraceae) – A Promising Traditionally used Endemic Medicinal Plant from Mauritius
Current Traditional Medicine Cannabinoids and Neuropathic Pain
Mini-Reviews in Medicinal Chemistry Treatment for Diabetic Peripheral Neuropathy: What have we Learned from Animal Models?
Current Diabetes Reviews